Buchumschlag

Immunotherapy in cancer: novel approaches and future perspectives

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Barbara Stefanska, Shafaat A. Rabbani
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Natural products and cancer: From drug discovery to prevention and therapy
von: Angelo A. Izzo, et al.
Veröffentlicht: (2025)

Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer
von: Éva Michaud, et al.
Veröffentlicht: (2024)

Natural product pharmacology: the British Journal of Pharmacology perspective
von: Xin Wang, et al.
Veröffentlicht: (2024)

Amylin analogues as a novel perspective in anti‐obesity therapy
von: Thomas A. Lutz
Veröffentlicht: (2026)

Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer
von: Ana Rita Simoes, et al.
Veröffentlicht: (2025)

Reporting innovations in pharmacology and drug development, upholding excellence and improving author experience at the British Journal of Pharmacology in 2024
von: Andreas Papapetropoulos, et al.
Veröffentlicht: (2025)

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
von: Stavros Topouzis, et al.
Veröffentlicht: (2025)

Updated BJP guidelines for transparent and rigorous natural product research
von: Xin Wang, et al.
Veröffentlicht: (2026)

Resveratrol, a novel inhibitor of fatty acid binding protein 5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways
von: Xiao Chen, et al.
Veröffentlicht: (2024)

IA‐0130, a novel 3‐(1,3‐diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL‐6/gp130/STAT3 signalling
von: Sun‐Ae Park, et al.
Veröffentlicht: (2025)

Psilocybin as a novel treatment for chronic pain
von: Tate Askey, et al.
Veröffentlicht: (2024)

The Australia story: Current status and future challenges for the clinical applications of psychedelics
von: David J Nutt, et al.
Veröffentlicht: (2024)

Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care
von: Anne Paulien Langermans, et al.
Veröffentlicht: (2026)

A novel approach to stratifying patients for medication review in the emergency department using medications and routine blood tests
von: Louise Westberg Strejby Christensen, et al.
Veröffentlicht: (2026)

Compartmentalisation in cAMP signalling: A phase separation perspective
von: Milda Folkmanaite, et al.
Veröffentlicht: (2025)

A novel role for microtubule affinity‐regulating kinases in neuropathic pain
von: Yao‐Qin Shi, et al.
Veröffentlicht: (2024)

Anti‐inflammatory effects of physical stimuli: The central role of networks in shaping the future of pharmacological research
von: Veronica Paparozzi, et al.
Veröffentlicht: (2025)

Role of microtubule affinity‐regulating kinases in epilepsy: A novel therapeutic strategy
von: Min Xu, et al.
Veröffentlicht: (2026)

Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator
von: Jiawei Zhang, et al.
Veröffentlicht: (2024)

Endothelium‐ and epithelium‐derived novel endogenous catecholamines as modulators of the autonomic nervous system
von: Mariana G. de Oliveira, et al.
Veröffentlicht: (2026)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
von: Dávid Nagy, et al.
Veröffentlicht: (2025)

Unravelling the multifaceted actions of neurosteroids: Machine learning and in vitro screening for novel target discovery
von: Ajeet Kumar, et al.
Veröffentlicht: (2025)

The future is now, old man
von: Marko Lucijanic, et al.
Veröffentlicht: (2024)

High‐throughput screen identifies MAS9 as a novel inhibitor of the C‐type lectin receptor‐2 (CLEC‐2)–podoplanin interaction
von: Marcin A. Sowa, et al.
Veröffentlicht: (2025)

Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects
von: Louise M. Hesketh, et al.
Veröffentlicht: (2026)

Cathepsins: Novel opportunities for antibody therapeutics in cancer
von: Timothée David, et al.
Veröffentlicht: (2025)

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology
von: Lucas Wittenkeller, et al.
Veröffentlicht: (2025)

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
von: Jae‐Hun Ahn, et al.
Veröffentlicht: (2025)

Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways
von: Paola Rogliani, et al.
Veröffentlicht: (2025)

Schedule‐dependent neuroprotection by pioglitazone in a novel model of α‐synucleinopathy in rats: Integrated behavioural and histological outcomes
von: Alberto Santiago‐Balmaseda, et al.
Veröffentlicht: (2026)

Role of monocarboxylate transporters in cancer immunology and their therapeutic potential
von: Ferdos Faghihkhorasani, et al.
Veröffentlicht: (2025)

A comprehensive review of cancer‐induced cardiac wasting
von: Alessia Lena, et al.
Veröffentlicht: (2026)

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy
von: Zihan Qu, et al.
Veröffentlicht: (2024)

Anti‐mitotic agent SB‐216 overcomes taxane resistance in castration‐resistant prostate cancer and exhibits anti‐tumour efficacy in pancreatic cancer
von: Rui Wang, et al.
Veröffentlicht: (2025)

A novel reuptake inhibitor, IP2015, induces erection by increasing central dopamine and peripheral nitric oxide release
von: Simon Comerma‐Steffensen, et al.
Veröffentlicht: (2024)

A novel marine‐derived mitophagy inducer ameliorates mitochondrial dysfunction and thermal hypersensitivity in paclitaxel‐induced peripheral neuropathy
von: Sangwoo Im, et al.
Veröffentlicht: (2024)

Past, present and future of drug safety: Editorial
von: Michael Rieder, et al.
Veröffentlicht: (2024)

Microscopy and spectroscopy approaches to study GPCR structure and function
von: Tomáš Fessl, et al.
Veröffentlicht: (2024)

Potential of natural flavonoids to target breast cancer angiogenesis (review)
von: Yuetong Wang, et al.
Veröffentlicht: (2024)

Opioids in breast cancer: Between analgesia and modulation of tumour progression
von: Marianna Ciwun, et al.
Veröffentlicht: (2026)